A Revolutionary Kidney Stone Treatment
No Anesthesia. No Stents.
Breaking the barrier to rapid treatment access.
At Avvio Medical, we are transforming the standard of care for urinary stone disease with a cutting-edge, office-based procedure that reduces wait times and eliminates the need for stents or general anesthesia.
Our innovative technology uses low-pressure ultrasound to activate calcium-seeking microbubbles, creating millions of micro-jets that break down stones. This approach aims to not only enhance patient safety and comfort but also lowers overall medical costs, offering a more accessible solution for stone treatment.
Bench demonstration of synthetic stone comminution using microbubbles and low-pressure ultrasound.
Accelerated time-lapse of actual treatment.
Minimally Invasive
Our office-based procedure eliminates the need for general anesthesia or stents.
Faster Treatment
Shorter wait times streamline care, allowing for quicker stone passage and patient recovery.
Expanded Access
By eliminating the need for anesthesia and stents, procedures can be done in outpatient clinics or rural settings, reducing the need for specialized facilities.
Cost-Effective
The procedure reduces overall medical costs by avoiding stenting and anesthesia.
See how it works
Avvio Lithotripsy VS Current Standard of Care
AVVIO has the potential to accelerate stone care from weeks to days – avoiding delays, stents, and general anesthesia. The goal: to help patients get faster, simpler treatment with fewer steps and less disruption.
News & Events
See moreAvvio Medical Receives FDA Breakthrough Device Designation for the Avvio Enhanced Lithotripsy System (ELS)
October 28, 2025 | Press Release
San Francisco, CA – October 28, 2025 – Avvio Medical, Inc., a clinical-stage medical device company developing next-generation kidney stone treatment technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to the…Avvio Medical Announces New CPT Code for Its Breakthrough Kidney Stone Treatment Technology
July 25, 2025 | Press Release
San Francisco, California – July 22, 2025 – Avvio Medical, Inc., a company dedicated to revolutionizing the treatment of urinary stones, is excited to announce that the American Medical Association (AMA) has officially published the early release of a new…Avvio Medical’s Microbubble Technology Reduces Complications and Shows Promise for Enhancing Laser Lithotripsy: AEROLITH Trial Results Published in The Journal of Urology
July 8, 2025 | Press Release
San Francisco, CA – July 8, 2025 – Avvio Medical Inc. today announced the publication of its AEROLITH randomized clinical trial in The Journal of Urology. Study highlights were presented at the 2025 American Urological Association (AUA) Annual Meeting in…
*Data on file
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision Q, September 2025.